Neuland Laboratories, Cato Research sign 70:30 JV
New Delhi, Oct 1 (UNI) Neuland Laboratories Ltd and US-based Cato Research Ltd today entered into 70: 30 Joint Venture (JV) for carrying on CRO business in the country.
The JV is likely to kick-start CRO business within 12 months, a company statement said.
Neuland is operating from the country for over two decades. The company is the preferred source for the pharmaceutical industry across the globe, with strengths in research-based chemistry and manufacturing.
UNI
Comments
Story first published: Wednesday, October 3, 2007, 14:21 [IST]